We are live on ! Find out more
CIA

Concurrent Investment Advisors Portfolio holdings

AUM $11.8B
1-Year Est. Return 31.86%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+31.86%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.48B
AUM Growth
+$363M
Cap. Flow
+$178M
Cap. Flow %
7.19%
Top 10 Hldgs %
19.73%
Holding
1,018
New
172
Increased
383
Reduced
320
Closed
96
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GREK
451
Global X MSCI Greece ETF
GREK
$320M
$725K 0.03%
+18,127
New +$717K
AGCO icon
452
AGCO
AGCO
$7.51B
$723K 0.03%
5,880
+812
+16% +$94.6K
UNIT
453
Uniti Group
UNIT
$2.44B
$721K 0.03%
122,250
-7,423
-6% -$42.4K
FTSM icon
454
First Trust Enhanced Short Maturity ETF
FTSM
$6.5B
$715K 0.03%
11,987
-5,644
-32% -$337K
VGIT icon
455
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
$710K 0.03%
12,135
-18,546
-60% -$1.09M
EMB icon
456
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$704K 0.03%
7,854
-496
-6% -$43.7K
MELI icon
457
Mercado Libre
MELI
$95.7B
$704K 0.03%
466
-35
-7% -$57.3K
NOC icon
458
Northrop Grumman
NOC
$78.4B
$701K 0.03%
1,466
-54
-4% -$24.9K
JAZZ icon
459
Jazz Pharmaceuticals
JAZZ
$16.4B
$701K 0.03%
+5,824
New +$713K
HCA icon
460
HCA Healthcare
HCA
$86.8B
$700K 0.03%
2,100
+152
+8% +$46.4K
ADM icon
461
Archer Daniels Midland
ADM
$38.5B
$694K 0.03%
11,049
-7,360
-40% -$432K
AMPH icon
462
Amphastar Pharmaceuticals
AMPH
$877M
$693K 0.03%
+15,778
New +$815K
FDX icon
463
FedEx
FDX
$74.1B
$692K 0.03%
2,389
-46
-2% -$11.5K
ELV icon
464
Elevance Health
ELV
$82B
$687K 0.03%
1,325
-10
-0.7% -$4.97K
JMEE icon
465
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
$2.95B
$685K 0.03%
11,708
+116
+1% +$6.34K
CHRW icon
466
C.H. Robinson
CHRW
$18.1B
$681K 0.03%
8,943
+5,462
+157% +$427K
SPTN
467
DELISTED
SpartanNash
SPTN
$679K 0.03%
+33,592
New +$724K
WELL icon
468
Welltower
WELL
$167B
$678K 0.03%
7,257
-424
-6% -$38.4K
TIP icon
469
iShares TIPS Bond ETF
TIP
$14.5B
$677K 0.03%
6,307
-3,714
-37% -$397K
ARES icon
470
Ares Management
ARES
$32.2B
$677K 0.03%
5,093
-750
-13% -$95.8K
CCI icon
471
Crown Castle
CCI
$33.9B
$673K 0.03%
6,359
-5,647
-47% -$614K
HTLD icon
472
Heartland Express
HTLD
$990M
$673K 0.03%
+56,327
New +$716K
C icon
473
Citigroup
C
$230B
$669K 0.03%
10,583
+271
+3% +$15.1K
RNAM
474
DELISTED
Avidity Biosciences
RNAM
$664K 0.03%
+26,005
New +$408K
DGRO icon
475
iShares Core Dividend Growth ETF
DGRO
$43.4B
$663K 0.03%
11,413
-10,615
-48% -$589K

Similar funds

Concurrent Investment Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Concurrent Investment Advisors held 1,018 positions worth $2.48B, up 17% from $2.12B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Concurrent Investment Advisors deployed $178M of net new capital in Q1 2024, opening 172 new positions and adding to 383 existing holdings. Its largest new stake was Capital Group Core Plus Income ETF: 194,440 shares worth $4.37M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares S&P Mid-Cap 400 Growth ETF, an estimated $10.6M trimmed.

  • Concurrent Investment Advisors's largest Q1 2024 buy was Capital Group Core Plus Income ETF: 194,440 shares worth $4.37M.
  • Concurrent Investment Advisors added most to PIMCO Active Bond Exchange-Traded Fund in Q1 2024, an estimated $20.3M increase.
  • Concurrent Investment Advisors's biggest Q1 2024 reduction was iShares S&P Mid-Cap 400 Growth ETF, cutting an estimated $10.6M.
  • Concurrent Investment Advisors fully exited Invesco BulletShares 2024 Corporate Bond ETF in Q1 2024, selling an estimated $1.79M.
  • Concurrent Investment Advisors's ten largest holdings make up 20% of its $2.48B portfolio in Q1 2024.
  • Concurrent Investment Advisors opened 172 new positions and closed 96 in Q1 2024.
  • Concurrent Investment Advisors's portfolio value rose 17% quarter-over-quarter to $2.48B.

Based on Concurrent Investment Advisors's 13F filing for Q1 2024, filed 7 May 2024.